A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis

Overview of attention for article published in Clinical Sarcoma Research, September 2019

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 412 followers.

Read about our work to describe CDKN2A deletion as a novel prognostic biomarker in soft tissue sarcoma! https://t.co/uNlJU2ynqE

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.